Changes in the Ca2+-activated K+ channels of the coronary artery during left ventricular hypertrophy

Circulation Research

Volumn 93, Issue 6, 2003, Pages 541-547

  Kim, Nari ^a   Chung, Joonyong ^a   Kim, Euiyong ^a   Han, Jin ^a  

^a Inje University   (South Korea)

Author keywords

KCa channels; Left ventricular hypertrophy; Reduced coronary reserve; Smooth muscle cells

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; ISOPRENALINE; POTASSIUM CHANNEL; POTASSIUM ION; TETRYLAMMONIUM; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; CYTOLOGY; ELECTRIC CONDUCTIVITY; HEART CONTRACTION; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; RABBIT; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; CORONARY VESSELS; ELECTRIC CONDUCTIVITY; HYPERTROPHY, LEFT VENTRICULAR; ISOPROTERENOL; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN SUBUNITS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0141608994     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000090087.66390.F2     Document Type: Article

References (45)

1. + channels. J Physiol. 1998;508:211-221.
2. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
3. + currents in rabbit coronary myocytes. Am J Physiol. 1994;266:C1523-C1537.
4. + channels. Circ Res. 1996;79:1024-1030.
5. Ashruf JF, Ince C, Bruining HA. Regional ischemia in hypertrophic Langendorff-perfused rat hearts. Am J Physiol. 1999;277:H1532-H1539.
6. Bache RJ. Effects of hypertrophy on the coronary circulation. Prog Cardiovasc Dis. 1988;30:403-440.
7. Kohya T, Kimura S, Myerburg RJ, Bassett AL. Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischemia. J Mol Cell Cardiol. 1988;20:159-168.
8. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88:993-1003.
9. Hittinger L, Mirsky I, Shen YT, Patrick TA, Bishop SP, Vatner SF. Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation. 1995;92:978-986.
10. Burke AP, Farb A, Liang YH, Smialek J, Virmani R. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation. 1996;94:3138-3145.
11. O'Keefe JH, Owen RM, Bove AA. Influence of left ventricular mass on coronary artery cross-sectional area. Am J Cardiol. 1987;59:1395-1397.
12. Kaufmann P, Vassalli G, Lupi-Wagner S, Jenni R, Hess OM. Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol. 1996;28:745-750.
13. Cuspidi C, Lonati L, Sampieri L, Valagussa L, Michev I, Leonetti G, Zanchetti A. Lack of correlation between left ventricular mass and diameter of left coronary artery main trunk in hypertensive patients. Am J Hypertens. 1999;12:1163-1168.
14. Bishop SP, Powell PC, Hasebe N, Shen YT, Patrick TA, Hittinger L, Vatner SF. Coronary vascular morphology in pressure-overload left ventricular hypertrophy. J Mol Cell Cardiol. 1996;28:141-154.
15. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
16. Gillis AM, Mathison HJ, Patel C, Lester WM. Quinidine pharmacodynamics in normal and isoproterenol-induced hypertrophied blood-perfused working rabbit hearts. J Cardiovasc Pharmacol. 1996;27:916-926.
17. 1-receptor stimulation in rabbit coronary artery cells. J Physiol. 1993;468:379-400.
18. + current of rabbit coronary arterial myocytes in isoprenaline-induced hypertrophy. Korean J Physiol Pharmacol. 2001;5:33-40.
19. + channels in aorta of hypertensive rats. Hypertension. 1997;30:1403-1409.
20. + current in arterial membranes from genetically hypertensive rats. Am J Physiol. 1993;264:H1337-H1345.
21. + channel. J Biol Chem. 1995;270:22434-22439.
22. + channels in the protective effect of ACE inhibition against ischemic myocardial injury. Hypertension. 1998;31:1290-1298.
23. + channels in hypertension. Clin Exp Pharmacol Physiol. 1996;23:1077-1081.
24. Ca channel activity in coronary artery smooth muscle cells. Circ Res. 2000;86:897-905.
25. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW. Vasoregulation by the β1 subunit of the calcium-activated potassium channel. Nature. 2000;407:870-876.
26. + currents in rabbit coronary artery cells near resting membrane potential. Can J Physiol Pharmacol. 1997;75:1116-1122.
27. ++ stores. J Pharmacol Exp Ther. 1998;284:838-846.
28. + channels in rabbit coronary myocytes. Circ Res. 1999;84:1032-1042.
29. + channel. J Biol Chem. 1995;270:22434-22439.
30. Moss BL, Magleby KL. Gating and conductance properties of BK channels are modulated by the S9-S10 tail domain of the a subunit: a study of mSlo1 and mSlo3 wild-type and chimeric channels. J Gen Physiol. 2001;118:711-734.
31. 2+ spark/STOC coupling and elevated blood pressure. Circ Res. 2000;87:e53-e60.
32. Ca, a unique member of the voltage-gated K channel superfamily. News Physiol Sci. 1998;13:112-117.
33. + channels in hypertension. Clin Exp Pharmacol Physiol. 1996;23:1077-1081.
34. Saito M, Nelson C, Salkoff L, Lingle CJ. A cysteine-rich domain defined by a novel exon in a slo variant in rat adrenal chromaffin cells and PC12 cells. J Biol Chem. 1997;272:11710-11717.
35. + channel isoforms from human brain. Neuron. 1994;13:1315-1330.
36. Meera P, Wallner M, Jiang Z, Toro L. Calcium switch for the functional coupling between α (hslo) and β subunits (KV, Ca β) of maxi K channels. FEBS Lett. 1996;382:84-88.
37. Tanaka Y, Meera P, Song M, Knaus HG, Toro L. Molecular constituents of maxi KCa channels in human coronary smooth muscle: predominant α+β subunit complexes. J Physiol. 1997;502:545-557.
38. Dworetzky SI, Boissard CG, Lum-Ragan JT, McKay MC, Post-Munson DJ, Trojnacki JT, Chang CP, Gribkoff VK. Phenotypic alteration of a human BK (hSlo) channel by hSloβ subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci. 1996;16:4543-4550.
39. Pellieux C, Sauthier T, Aubert JF, Brunner HR, Pedrazzini T. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice. J Hypertens. 2000;18:1307-1317.
40. Takeishi Y, Huang Q, Abe J, Glassman M, Che W, Lee JD, Kawakatsu H, Lawrence EG, Hoit BD, Berk BC, Walsh RA. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol. 2001;33:1637-1648.
41. Murat A, Pellieux C, Brunner HR, Pedrazzini T. Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension. J Biol Chem. 2000;275:40867-40873.
42. Yamazaki T, Komuro I, Yazaki Y. Molecular aspects of mechanical stress-induced cardiac hypertrophy. Mol Cell Biochem. 1996;163-164:197-201.
43. Zimmer HG. Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J Mol Med. 1997;75:849-859.
44. Sylvester AM, Chen D, Krasinski K, Andres V. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest. 1998;101:940-948.
45. 2+ entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol. 2001;281:H2559-2567.